Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Amortization of Deferred Charges (2016 - 2026)

Viridian Therapeutics, Inc.\DE has reported Amortization of Deferred Charges over the past 8 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Amortization of Deferred Charges at $2.3 million for Q4 2025, up 3727.12% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (up 580.64% YoY), and the annual figure for FY2025 was $2.6 million, up 580.64%.
  • Amortization of Deferred Charges for Q4 2025 was $2.3 million at Viridian Therapeutics, Inc.\DE, up from $102000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for VRDN hit a ceiling of $2.3 million in Q4 2025 and a floor of $49000.0 in Q3 2022.
  • Median Amortization of Deferred Charges over the past 5 years was $94500.0 (2021), compared with a mean of $223437.5.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 52.03% in 2024 and later skyrocketed 3727.12% in 2025.
  • Viridian Therapeutics, Inc.\DE's Amortization of Deferred Charges stood at $87000.0 in 2021, then soared by 47.13% to $128000.0 in 2022, then dropped by 3.91% to $123000.0 in 2023, then plummeted by 52.03% to $59000.0 in 2024, then skyrocketed by 3727.12% to $2.3 million in 2025.
  • The last three reported values for Amortization of Deferred Charges were $2.3 million (Q4 2025), $102000.0 (Q3 2025), and $103000.0 (Q2 2025) per Business Quant data.